Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
10.6M
-
Shares change
-
-1.19M
-
Total reported value, excl. options
-
$12.9M
-
Value change
-
-$2.02M
-
Number of buys
-
6
-
Number of sells
-
-16
-
Price
-
$1.21
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q3 2019
31 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q3 2019.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.6M shares
of 386M outstanding shares and own 2.75% of the company stock.
Largest 10 shareholders include STONEHILL CAPITAL MANAGEMENT LLC (2.86M shares), Paradice Investment Management LLC (1.54M shares), HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (1.49M shares), FIRST WILSHIRE SECURITIES MANAGEMENT INC (773K shares), JANUS HENDERSON GROUP PLC (731K shares), Fondren Management LP (720K shares), RENAISSANCE TECHNOLOGIES LLC (680K shares), HEARTLAND ADVISORS INC (565K shares), MORGAN STANLEY (461K shares), and Adirondack Research & Management Inc. (416K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.